MindWalk Holdings Corp. (TQB0)

Overview

MindWalk Holdings Corp. is a pioneering bio-native AI company focused on the innovative integration of artificial intelligence with multi-omics data. By leveraging advanced laboratory research techniques, the company aims to expedite the discovery and development of biologics. With its proprietary LensAI platform and HYFT technology, MindWalk collaborates with pharmaceutical and biotechnology firms to minimize risks in drug development and unlock new therapeutic possibilities. Originally founded as ImmunoPrecise Antibodies Ltd., the company underwent a name change to MindWalk Holdings Corp. in September 2025. Established in 1983, it is headquartered in Austin, Texas.

Products and Services

• LensAI Platform

  The LensAI platform is at the forefront of MindWalk's technology offerings, employing advanced algorithms to analyze complex biological data. This platform aids in identifying valuable insights that can significantly enhance drug discovery processes.

• HYFT Technology

  HYFT technology enables the integration of heterogeneous multi-omics data sources, thus providing a comprehensive understanding of biological systems. This technology supports researchers in drawing valuable correlations and facilitating decision-making processes in drug development.

• Collaborative Partnerships

  MindWalk partners with leading pharmaceutical and biotechnology companies, providing them with tailored solutions that streamline their research and development efforts. These collaborations focus on de-risking drug development by leveraging cutting-edge AI technologies and multi-dimensional data analysis.

• Research and Development Support

  In addition to its technological platforms, MindWalk offers extensive research and development support. This service encompasses a range of laboratory research capabilities and consulting services aimed at enhancing the efficiency and effectiveness of client projects.